Population
Patients with type 1 and type 2 diabetes developing diabetic kidney disease
Design
Review
Authors
Loading...
Offers mechanistic synthesis for DKD; leaves open which targets merit prioritized clinical trials.
This review summarizes the complex interplay of metabolic, hemodynamic, intracellular, and growth factor pathways in the pathogenesis of diabetic kidney disease and discusses potential therapeutic targets.
Schrijvers et al. (2004) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: